Defence Therapeutics Inc. (CSE:DTC)
Canada
· Delayed Price · Currency is CAD 0.880
-0.020 (-2.22%)
At close: Dec 5, 2025
Defence Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2019 |
| Cash & Equivalents | 2.32 | 1.23 | 0.06 | 2.79 | 0.51 | 5.45 | Upgrade
|
| Cash & Short-Term Investments | 2.32 | 1.23 | 0.06 | 2.79 | 0.51 | 5.45 | Upgrade
|
| Cash Growth | 1669.07% | 2079.47% | -97.97% | 451.20% | -90.71% | 192.24% | Upgrade
|
| Other Receivables | 0.22 | 0.2 | 0.1 | 0.15 | 0.03 | 0.07 | Upgrade
|
| Receivables | 0.22 | 0.2 | 0.1 | 0.15 | 0.03 | 0.07 | Upgrade
|
| Prepaid Expenses | 0.03 | 0.03 | 0.06 | 0.49 | 0.14 | 0.04 | Upgrade
|
| Total Current Assets | 2.58 | 1.46 | 0.21 | 3.43 | 0.67 | 5.56 | Upgrade
|
| Property, Plant & Equipment | 0.19 | 0.19 | 0.26 | 0.06 | - | - | Upgrade
|
| Other Intangible Assets | - | - | - | 0.04 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 2.77 | 1.65 | 0.48 | 3.53 | 0.72 | 5.61 | Upgrade
|
| Accounts Payable | 1.13 | 1.33 | 2.09 | 0.19 | 0.98 | 0.11 | Upgrade
|
| Short-Term Debt | - | - | 0.05 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 1.56 | 1.49 | 1.66 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 0.02 | 0.03 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.07 | 0.07 | 0.22 | 0.03 | 0.13 | 0.01 | Upgrade
|
| Total Current Liabilities | 2.76 | 2.91 | 4.05 | 0.22 | 1.11 | 0.12 | Upgrade
|
| Long-Term Debt | - | - | - | 1.75 | - | - | Upgrade
|
| Long-Term Leases | 1.41 | - | 0.01 | - | - | - | Upgrade
|
| Total Liabilities | 4.18 | 2.91 | 4.06 | 1.97 | 1.11 | 0.12 | Upgrade
|
| Common Stock | 24.19 | 24.19 | 19.24 | 16.95 | 9.33 | 7.97 | Upgrade
|
| Retained Earnings | -30.02 | -29.31 | -29.81 | -16.91 | -10.52 | -3.53 | Upgrade
|
| Comprehensive Income & Other | 4.42 | 3.86 | 6.98 | 1.52 | 0.79 | 1.05 | Upgrade
|
| Shareholders' Equity | -1.41 | -1.26 | -3.58 | 1.57 | -0.39 | 5.49 | Upgrade
|
| Total Liabilities & Equity | 2.77 | 1.65 | 0.48 | 3.53 | 0.72 | 5.61 | Upgrade
|
| Total Debt | 2.97 | 1.5 | 1.75 | 1.75 | - | - | Upgrade
|
| Net Cash (Debt) | -0.65 | -0.27 | -1.69 | 1.05 | 0.51 | 5.45 | Upgrade
|
| Net Cash Growth | - | - | - | 106.61% | -90.71% | 192.24% | Upgrade
|
| Net Cash Per Share | -0.01 | -0.01 | -0.04 | 0.03 | 0.01 | 0.21 | Upgrade
|
| Filing Date Shares Outstanding | 54.73 | 54.73 | 45.54 | 44.27 | 37.68 | 35.96 | Upgrade
|
| Total Common Shares Outstanding | 54.73 | 54.73 | 45.54 | 43.78 | 36.63 | 35.22 | Upgrade
|
| Working Capital | -0.19 | -1.44 | -3.84 | 3.21 | -0.43 | 5.44 | Upgrade
|
| Book Value Per Share | -0.03 | -0.02 | -0.08 | 0.04 | -0.01 | 0.16 | Upgrade
|
| Tangible Book Value | -1.41 | -1.26 | -3.58 | 1.53 | -0.43 | 5.44 | Upgrade
|
| Tangible Book Value Per Share | -0.03 | -0.02 | -0.08 | 0.03 | -0.01 | 0.15 | Upgrade
|
| Machinery | 0.29 | 0.27 | 0.27 | 0.07 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.